Date: Wed, 18 Nov 98 05:30:59 EST From: abby@seirei-wjc.ac.jp To: angel@worldnet.att.net Subject: NLAB News Release Message-ID: <19981110093369.TVA471825@gte.net>
next in thread | raw e-mail | index | archive | help
Tuesday November 17, 1:05 pm Eastern Time Company Press Release NuOncology Labs Engages EBI Securities VIRGINIA BEACH, Va.--(BUSINESS WIRE)--Nov. 17, 1998--NuOncology Labs Inc. (OTC BB:NLAB - news) announced Tuesday that it has engaged EBI Securities Corp. to provide consulting services and advice to NuOncology Labs concerning business and financial planning, corporate organization and structure, private and public equity and debt financing, acquisitions, mergers and other similar business combinations. EBI Securities, a wholly owned subsidiary of Eastbrokers International Incorporated [Nasdaq:EASEC - news], is headquartered in Rockville, Md. EBI has over 20 offices in the United States and 12 offices located throughout Central and Eastern Europe. NuOncology Labs Inc. participates in the multi-billion dollar cancer treatment research and clinical laboratories industries by supporting the research, development, testing and licensing of cancer treatments along with the delivery of predictive tests for the optimization of contemporary cancer treatment. Additional corporate and financial information regarding NuOncology Labs, Inc. is available through and contained in an information disclosure statement provided to brokers pursuant to Rule 15c2-11 of the Securities Exchange Act of 1934 (the ``Act''). Note: Statements in this document that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors, including risks relating to the early state of products under development; uncertainties relating to clinical trials; dependence on third parties; future capital needs; and risks relating to the commercialization, if any, of the Company's proposed products (such as marketing, safety, regulatory, patent, product liability, supply, competition and other risks). NuOncology Labs Inc. trades on the OTC Electronic Bulletin Board under the symbol "NLAB". Contact: Donna Schmidt, 303-516-1447 More Quotes and News: Eastbrokers International Inc (Nasdaq:EASEC - news) NuOncology Labs Inc (OTC BB:NLAB - news) Related News Categories: banking, medical/pharmaceutical To Unsubscribe: send mail to majordomo@FreeBSD.org with "unsubscribe freebsd-doc" in the body of the message
Want to link to this message? Use this URL: <https://mail-archive.FreeBSD.org/cgi/mid.cgi?19981110093369.TVA471825>